These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 9495517

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Bone markers after total body irradiation in childhood.
    Couto-Silva AC, Trivin C, Espérou H, Michon J, Baruchel A, Souberbielle JC, Brauner R.
    Bone Marrow Transplant; 2010 Mar; 45(3):437-41. PubMed ID: 19684622
    [Abstract] [Full Text] [Related]

  • 43. Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women.
    Burman P, Johansson AG, Siegbahn A, Vessby B, Karlsson FA.
    J Clin Endocrinol Metab; 1997 Feb; 82(2):550-5. PubMed ID: 9024252
    [Abstract] [Full Text] [Related]

  • 44. Effects of growth hormone replacement on parathyroid hormone sensitivity and bone mineral metabolism.
    Ahmad AM, Thomas J, Clewes A, Hopkins MT, Guzder R, Ibrahim H, Durham BH, Vora JP, Fraser WD.
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2860-8. PubMed ID: 12788900
    [Abstract] [Full Text] [Related]

  • 45. PICP as bone formation and NTx as bone resorption marker in patients with chronic renal failure.
    Franke S, Lehmann G, Abendroth K, Hein G, Stein G.
    Eur J Med Res; 1998 Feb 21; 3(1-2):81-8. PubMed ID: 9512973
    [Abstract] [Full Text] [Related]

  • 46. Effects of 12-month GH treatment on bone metabolism and bone mineral density in adults with adult-onset GH deficiency.
    Sartorio A, Ortolani S, Galbiati E, Conte G, Vangeli V, Arosio M, Porretti S, Faglia G.
    J Endocrinol Invest; 2001 Apr 21; 24(4):224-30. PubMed ID: 11383908
    [Abstract] [Full Text] [Related]

  • 47. Influence of lighting conditions on daily rhythm of bone metabolism in rats and possible involvement of melatonin and other hormones in this process.
    Ostrowska Z, Kos-Kudla B, Marek B, Kajdaniuk D.
    Endocr Regul; 2003 Sep 21; 37(3):163-74. PubMed ID: 14986722
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Insulin-like growth factor-I raises serum procollagen levels in children and adults with Laron syndrome.
    Klinger B, Jensen LT, Silbergeld A, Laron Z.
    Clin Endocrinol (Oxf); 1996 Oct 21; 45(4):423-9. PubMed ID: 8959080
    [Abstract] [Full Text] [Related]

  • 50. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.
    Yuen KCJ, Biller BMK, Radovick S, Carmichael JD, Jasim S, Pantalone KM, Hoffman AR.
    Endocr Pract; 2019 Nov 21; 25(11):1191-1232. PubMed ID: 31760824
    [Abstract] [Full Text] [Related]

  • 51. A 12-month longitudinal study of calcium metabolism and bone turnover during valproate monotherapy.
    Verrotti A, Agostinelli S, Coppola G, Parisi P, Chiarelli F.
    Eur J Neurol; 2010 Feb 21; 17(2):232-7. PubMed ID: 19682062
    [Abstract] [Full Text] [Related]

  • 52. Growth hormone treatment in adults with GH deficiency: effects on new biochemical markers of bone and collagen turnover.
    Sartorio A, Conti A, Monzani M, Morabito F, Faglia G.
    J Endocrinol Invest; 1993 Dec 21; 16(11):893-8. PubMed ID: 8144866
    [Abstract] [Full Text] [Related]

  • 53. From isolated GH deficiency to multiple pituitary hormone deficiency: an evolving continuum - a KIMS analysis.
    Klose M, Jonsson B, Abs R, Popovic V, Koltowska-Häggström M, Saller B, Feldt-Rasmussen U, Kourides I.
    Eur J Endocrinol; 2009 Nov 21; 161 Suppl 1():S75-83. PubMed ID: 19684053
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study. The GH-2000 Study Group.
    Longobardi S, Keay N, Ehrnborg C, Cittadini A, Rosén T, Dall R, Boroujerdi MA, Bassett EE, Healy ML, Pentecost C, Wallace JD, Powrie J, Jørgensen JO, Saccà L.
    J Clin Endocrinol Metab; 2000 Apr 21; 85(4):1505-12. PubMed ID: 10770189
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Long-Term Outcomes, Genetics, and Pituitary Morphology in Patients with Isolated Growth Hormone Deficiency and Multiple Pituitary Hormone Deficiencies: A Single-Centre Experience of Four Decades of Growth Hormone Replacement.
    Rohayem J, Drechsel H, Tittel B, Hahn G, Pfaeffle R, Huebner A.
    Horm Res Paediatr; 2016 Apr 21; 86(2):106-116. PubMed ID: 27487097
    [Abstract] [Full Text] [Related]

  • 59. The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density.
    Wüster C, Abs R, Bengtsson BA, Bennmarker H, Feldt-Rasmussen U, Hernberg-Ståhl E, Monson JP, Westberg B, Wilton P, KIMS Study Group and the KIMS International Board. Pharmacia & Upjohn International Metabolic Database.
    J Bone Miner Res; 2001 Feb 21; 16(2):398-405. PubMed ID: 11204440
    [Abstract] [Full Text] [Related]

  • 60. [Osteopenia caused by growth hormone deficiency in childhood].
    Mochizuki H, Aizu K.
    Nihon Rinsho; 2005 Oct 21; 63 Suppl 10():577-81. PubMed ID: 16279704
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.